Principle of Assay
Human Somatostatin ELISA Kit (A79723) employs the competitive enzyme immunoassay technique for the quantitative measurement of human Somatostatin in serum, plasma, tissue homogenates, and other biological fluids. The 96-well microtiter plate has been pre-coated with Somatostatin antigen. During the incubation, Somatostatin present in the samples or standards competes with the fixed amount of immobilized Somatostatin for binding sites on the Biotinylated Anti-Somatostatin Antibody. The more Somatostatin present in a sample or standard, the less Biotinylated Anti-Somatostatin Antibody that binds to the plate. Following incubation, unbound Biotinylated Anti-Somatostatin Antibody is removed by washing, and an HRP-Streptavidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is inversely proportional to the amount of Somatostatin present in each sample or standard. The concentration of Somatostatin can then be calculated by reading the O.D. absorbance at 450nm in a microplate reader and referring to the standard curve.
